Class IIa 2. In patients with TAA, regardless of cause and in the absence of contraindications, use of beta blockers to achieve target BP goals is reasonable. (Level of Evidence: C-LD) 3. In patients with TAA, regardless of etiology and in the absence of contraindications, ARB therapy is a reasonable adjunct to beta-blocker therapy to achieve target BP goals. (Level of Evidence: C-EO)
What exactly is an aortic aneurysm?
<s>[INST] Answer the question truthfully, you are a medical professional. This is the question: What exactly is an aortic aneurysm? [/INST] \n Class IIa 2. In patients with TAA, regardless of cause and in the absence of contraindications, use of beta blockers to achieve target BP goals is reasonable. (Level of Evidence: C-LD) 3. In patients with TAA, regardless of etiology and in the absence of contraindications, ARB therapy is a reasonable adjunct to beta-blocker therapy to achieve target BP goals. (Level of Evidence: C-EO)</s>